Director/PDMR Shareholding

RNS Number : 5532J

AstraZeneca PLC

31 March 2010

 



Transaction by Persons Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

We hereby inform you that on 30 March 2010, the interest of David Brennan, a Director of the Company, in AstraZeneca ordinary shares, changed as detailed below.  The change in interest relates to the vesting of a previously announced award made in March 2007 under the AstraZeneca Performance Share Plan whereby, following the application of performance measures specified at the time of grant, Mr Brennan has now become beneficially entitled to 78% of the shares originally awarded.  In accordance with the plan rules, the unvested part of the award has immediately and irrevocably lapsed.  Sufficient shares were withheld to cover certain tax obligations arising on the vesting.

Name of Director	Gross Shares Awarded	Shares Lapsed	Shares Vested	Shares Withheld	Net Shares Received	Market Price on Vesting
David R Brennan	107,051	23,552	83,499	34,235	49,264	2980p

Mr Brennan has interests in both the Ordinary Shares and the American Depositary Shares (ADSs) of AstraZeneca PLC.  One ADS equals one Ordinary Share.

As a result of this transaction, Mr Brennan now has an interest in 458,926 Ordinary Shares and 77,946 AstraZeneca ADSs, which together represent approximately 0.04% of the Company's issued ordinary capital.

A C N Kemp

Company Secretary

31 March 2010

 

END

 

 

RDSUARVRRAAOOAR